July 6 (Reuters) - Biotron Ltd BIT.AX :
* ADVISE THAT COMPANY IS PRESENTING NEW DATA ON ITS LEAD HIV-1 DRUG, BIT225
* DATA INDICATE THAT VIA ITS INHIBITION OF HIV-1 VIRAL PROTEIN VPU, BIT225 ENHANCES IMMUNE RESPONSE TO HIV
July 6 (Reuters) - Biotron Ltd BIT.AX :
* ADVISE THAT COMPANY IS PRESENTING NEW DATA ON ITS LEAD HIV-1 DRUG, BIT225
* DATA INDICATE THAT VIA ITS INHIBITION OF HIV-1 VIRAL PROTEIN VPU, BIT225 ENHANCES IMMUNE RESPONSE TO HIV